Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin in Children With Growth Retardation
NCT00488124Phase 2Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Nov 2005
- Primary completion
- Feb 2011
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label trial of somatropin in Idiopathic Short Stature (ISS), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Change in height Standard Deviation Score at 2 years. Started Nov 2005; status: completed.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT00488124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488124.